Cargando…
LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer
BACKGROUND: Colorectal cancer (CRC) is the third most prevalent malignancy and has the fourth highest global cancer mortality rate. Early diagnosis and prompt medical attention can improve quality of life and the prognosis of CRC patients. Accumulating evidence reveals that long non-coding RNAs (lnc...
Autores principales: | Wang, Wei, Xie, Ying, Chen, Fei, Liu, Xu, Zhong, Li-Li, Wang, Hai-Qiang, Li, Qing-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689807/ https://www.ncbi.nlm.nih.gov/pubmed/31413531 http://dx.doi.org/10.3748/wjg.v25.i29.3972 |
Ejemplares similares
-
Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization
por: Zhang, Qi, et al.
Publicado: (2022) -
LncRNA cancer susceptibility 20 regulates the metastasis of human gastric cancer cells via the miR-143-5p/MEMO1 molecular axis
por: Shan, Ke-Shu, et al.
Publicado: (2022) -
The novel lncRNA PTTG3P is downregulated and predicts poor prognosis in non-small cell lung cancer
por: Huang, Hai-Tao, et al.
Publicado: (2020) -
Construction of an oesophageal cancer-specific ceRNA network based on miRNA, lncRNA, and mRNA expression data
por: Xue, Wen-Hua, et al.
Publicado: (2018) -
Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells
por: Li, Ying, et al.
Publicado: (2016)